[1]
Gordon, K., Foley, P., Rich, P., Duffin, K., Pinter, A., Griffiths, C., Wang, M., Vanvoorden, V., Staelens, F., Ciaravino, V. and Merola, J. 2021. Bimekizumab Versus Ustekinumab in Plaque Psoriasis: Lasting Efficacy Translates to Rapid and Sustained Improvements in Quality of Life in the BE VIVID Multicenter, Randomized, Double-Blinded Phase 3 Trial. SKIN The Journal of Cutaneous Medicine. 5, 1 (Jan. 2021), s17. DOI:https://doi.org/10.25251/skin.5.supp.17.